Cordlife Group Limited
P8A
Rank in Stocks
#26769
Established in Singapore in 2001, Cordlife Group Limited functions as an... Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.
Share Price
$0.07115545
Last synced: 2026-11-10
Market Cap
$18.24M
Change (1 day)
-0.07%
Change (1 year)
-48.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cordlife Group Limited (P8A)
Category
Healthcare
EPS for Cordlife Group Limited (P8A)
EPS as of June 2026 TTM: $-0.03
According to Cordlife Group Limited's latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.04, an increase over its 2024 EPS of $-0.05.
EPS history for Cordlife Group Limited from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -18.75% |
| 2025 | $-0.04 | -29.34% |
| 2024 | $-0.05 | -616.19% |
| 2023 | $0.01 | -26.06% |
| 2022 | $0.01 | -20.22% |
| 2021 | $0.02 | 21.92% |
| 2020 | $0.01 | 4.29% |
| 2019 | $0.01 | 268.42% |
| 2018 | 0.00 | -323.53% |
| 2017 | 0.00 | -106.49% |
| 2016 | $0.03 | -61.92% |
| 2015 | $0.07 | -10.07% |
| 2014 | $0.08 | 67.40% |
| 2013 | $0.05 | 43.71% |
| 2012 | $0.03 | -2.75% |
| 2011 | $0.03 | 16.79% |
| 2010 | $0.03 | 38.61% |
| 2009 | $0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -58,530.77% |
US
|
|
| $6.12 | -18,930.77% |
US
|
|
| $1.38 | -4,337.23% |
CN
|
|
| $14.83 | -45,730.77% |
US
|
|
| $5.09 | -15,761.54% |
US
|
Questions about Cordlife Group Limited's earnings per share (EPS)
What is Cordlife Group Limited's earnings per share (EPS)?
Cordlife Group Limited's earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was Cordlife Group Limited's earnings per share (EPS) in 2025?
In 2025, Cordlife Group Limited's earnings per share (EPS) was $-0.04, compared with $-0.05 in 2024.
How has Cordlife Group Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cordlife Group Limited's earnings per share (EPS) was highest in 2021 ($0.02) and lowest in 2024 ($-0.05).
How does Cordlife Group Limited's earnings per share (EPS) compare with similar companies?
Cordlife Group Limited's earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.